Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
|Poll|March 11, 2020
Mini Quiz: Coronavirus Outbreak and Mental Illness
Author(s)Nidal Moukaddam, MD, PhD
Can outbreaks such as COVID-19 affect existing illnesses and precipitate new-onset psychiatric symptoms in children and adults?
Advertisement
Scroll down for the quiz question.
True or False: Outbreaks can potentially affect existing illnesses and precipitate new-onset mental symptoms in children or adults.
Advertisement
Related to this article
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
3
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
4
New Analyses of HLP003 for the Adjunctive Treatment of MDD
5